Literature DB >> 22172156

Hepatitis E virus antibodies in blood donors, France.

Jean-Michel Mansuy1, Richard Bendall, Florence Legrand-Abravanel, Karine Sauné, Marcel Miédouge, Vic Ellis, Henri Rech, François Destruel, Nassim Kamar, Harry R Dalton, Jacques Izopet.   

Abstract

Using a validated sensitive assay, we found hepatitis E virus (HEV) IgG in 52.5% of voluntary blood donors in southwestern France. This finding suggests HEV is highly endemic to this region. The high HEV prevalence may reflect local dietary practices, such as eating uncooked pork and game products.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172156      PMCID: PMC3311200          DOI: 10.3201/eid1712.110371

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


It is now recognized that hepatitis E virus infection is not confined to developing countries. HEV infection is a growing public health concern in industrialized countries where the disease is mainly autochthonous, caused by HEV genotypes 3 (Europe) and 4 (People’s Republic of China and Japan), and is thought to be zoonotic (). In a previous study, we estimated that 16.6% of blood donors in the Midi-Pyrénées region of southwestern France have HEV antibodies (). This rate was much higher than that measured in northern France (), which suggests differences between these 2 populations and their exposure to HEV that we wished to explore further. However, it is difficult to make wider comparisons with seroprevalence studies from other areas because the various assays used differed in sensitivity and specificity (). Because a recent study suggested that the HEV IgG assay we used in our original study lacks sensitivity (), we repeated and extended the study using a more sensitive assay that has been validated by using serum from PCR-proven HEV genotype 3 infections ().

The Study

During September 2003 through May 2004, serum samples were collected from 512 adult blood donors 18–64 years old (median 42 years) and 188 children 2–4 years old. The blood donors were unpaid voluntary donors; the children were hospitalized in Toulouse for surgery or trauma. All were residents of the Midi-Pyrénées region. The prevalence of HEV IgG was determined by using the Wantai HEV IgG enzyme immunoassay (Wantai Biologic Pharmacy Enterprise, Beijing, People’s Republic of China), according to the manufacturer’s instructions. Details of baseline demographic data and putative risk factors were collected from blood donors by using a structured questionnaire. In addition, to assess the risk for foodborne infection, we tested 18 local pig-liver sausages for HEV RNA using a quantitative real-time PCR based on the open reading frame 2 region of the HEV genome (). HEV IgG was detected in 268 (52.5%) of 512 (95% confidence interval [CI] 48.2%–56.8%) of the blood donors. Seroprevalence increased with age (Figure 1). The ranges of optical density/cutoff ratios for positive and negative samples showed a clear bimodal distribution (Figure 2). Of 244 rural donors, 63.1% (95% CI 57%–69.2%) were anti-HEV positive compared with 42.9% (95% CI 37–48.8) of 268 urban donors (p<0.01). For children, seroprevalence was 3.7% (95% CI 1.0%–6.5%). The mean ± SD optical density/cutoff ratio of the positive samples was 5.43 ± 3.93 for children and 5.99 ± 3.52 for adults. Although several factors were associated with the presence of HEV IgG after univariate analysis, multivariate analysis identified only age, rural residence, hunting, and contact with cats as factors independently associated with HEV IgG positivity (Table 1).
Figure 1

Prevalence of hepatitis E virus (HEV) IgG in 512 blood donors by age group, Midi-Pyrénées region, France, 2003–2004.

Figure 2

Distribution of optical density/cut off ratios for hepatitis E virus IgG in positive and negative samples from 512 blood donors, Midi-Pyrénées region, France, 2003–2004. Whiskers represent percentiles.

Table 1

Prevalence of HEV IgG, demographics, and potential risk factors for 512 blood donors, Midi-Pyrénées region, France, 2003–2004*

Analysis and risk factor
% Donors with HEV IgG
Odds ratio (95% CI)
p value
Univariate analysis
Age1.24
(1.14–1.35)<0.001
Sex, M/F51/551.14
(0.79–1.64)NS
Rural residence592.27
(1.60–3.25)<0.001
Gardening611.75
(1.22–2.5)<0.01
Kitchen gardening692.23
(1.30–3.87)<0.001
Hunting803.82
(1.41–10.4)<0.01
Contact with farm
animals571.6
(1.12–2.29)<0.01
Contact with dogs581.42
(0.99–2.0)NS
Contact with cats591.49
(0.04–2.13)<0.05
Contact with horses541.05
(0.35–3.17)NS
Contact with pigs500.89
(0.25–3.11)NS
Contact with poultry510.93
(0.49–1.80)NS
Contact with wild
animals742.73
(1.20–6.23)<0.05
Travel outside France520.54
(0.35–0.83)<0.01
Travel outside Europe500.58
(0.38–0.89)<0.05
Multivariate analysis
Age1.20
(1.10–1.31)<0.01
Rural residence1.80
(1.24–2.62)<0.01
Hunting4.11
(1.35–12.5)<0.05

Contact with cats

1.6
(1.10–2.34)

<0.05

*HEV, hepatitis E virus; CI, confidence interval; NS, not significant.

Prevalence of hepatitis E virus (HEV) IgG in 512 blood donors by age group, Midi-Pyrénées region, France, 2003–2004. Distribution of optical density/cut off ratios for hepatitis E virus IgG in positive and negative samples from 512 blood donors, Midi-Pyrénées region, France, 2003–2004. Whiskers represent percentiles. Contact with cats 1.6
(1.10–2.34) <0.05 *HEV, hepatitis E virus; CI, confidence interval; NS, not significant. HEV RNA was found in 8 (44%) of the 18 sausages tested by real-time PCR (Table 2). The virus load ranged from 100 (the limit of detection for this assay) to 668,520 copies/g. We attempted to genotype HEV RNA–positive samples by sequencing a 189-nt fragment of the open reading frame 2 gene (). This was successful only for the sample with the highest virus load. The virus was identified as HEV genotype 3.
Table 2

Detection and quantification by real-time PCR of HEV RNA in pig-liver sausages purchased from markets in the Midi-Pyrénées region, France, 2003–2004*

SampleMarketHEV RNAHEV RNA concentration†Genotype
1A1Negative
2A2Negative
3A3Negative
4A4Positive4,100NA
5A5Positive175NA
6A6Positive240NA
7A7Negative
8BPositive100NA
9CNegative
10DPositive8,200NA
11ENegative
12FPositive668,5203
13GNegative
14HNegative
15IPositive120NA
16JNegative
17KNegative
18LPositive48,550NA

*A1–A7 indicate different shops in the same market. HEV, hepatitis E virus; NA, no PCR amplification with primers used for genotyping.
†Copies/g.

*A1–A7 indicate different shops in the same market. HEV, hepatitis E virus; NA, no PCR amplification with primers used for genotyping.
†Copies/g.

Conclusions

We determined that the HEV IgG prevalence among blood donors in Midi-Pyrénées is 52.5%, the highest seroprevalence reported in an industrialized country. This rate is 3.1 times higher than our previous estimate (16.6%) for the same population (). The implication is that HEV is hyperendemic to Midi-Pyrénées. Although surprising, we believe these results are valid for several reasons. First, the Wantai assay used to assess HEV seroprevalence has been validated for this purpose in the United Kingdom, another region where HEV-3 predominates (). The greater proportion of reactive serum seen with this assay is unlikely to have resulted from nonspecific reactivity because the assay produced a clear distinction between negative and positive samples, and only a small proportion of young children tested positive. Our findings agree with those of another study that found a much increased HEV seroprevalence when the more accurate test was used (). Second, autochthonous HEV genotype 3 hepatitis in Midi-Pyrénées is common. The estimated rate of acquisition of HEV infection in organ transplant recipients in Toulouse is 3.2 per 100 person-years (). This figure is derived from regular monitoring by using sensitive molecular techniques and does not depend on serologic assays. As noted in other countries (,), the percentage of HEV-positive serum increased with age, which is consistent with cumulative exposure to infection over time. HEV is usually transmitted orally, and foodborne transmission of zoonotic strains has been demonstrated. Hunting of wild boar and deer is popular in Midi-Pyrénées, particularly in rural areas. Both species have been identified as sources of human infection (). The consumption of uncooked game meat, which is traditional in this area, could explain the high HEV antibody prevalence in 20 (80%) of 25 hunters. Further evidence comes from a case–control study among organ transplant recipients in Midi-Pyrénées that demonstrated that the only factor independently associated with HEV infection was consumption of game meat (). Some of these foods have been shown to contain HEV RNA, and phylogenetic analysis demonstrated that these strains were closely related to human strains (). Another suspected zoonotic source of HEV genotype 3 infection is the domestic pig (). Hepatitis E cases have been linked to eating uncooked pork-liver sausage in southeastern France (). We found that a high proportion (44%) of pig-liver sausages purchased in Toulouse contained HEV RNA. These air-dried sausages are popular in Midi-Pyrénées and are usually eaten raw. Their infectivity is unknown, but cell-culture experiments have demonstrated that high virus loads correlate with high infectivity (). In addition to direct foodborne transmission, the growing boar population in Midi-Pyrénées and the spreading of pig manure on land may pose indirect risks through fecal contamination of soil and watercourses. These 2 factors and the 2 foodborne sources of HEV might explain the high HEV antibody prevalence in Midi-Pyrénées and the statistical association of HEV seropositivity with rural residence and hunting, but they cannot explain the association with cat contact. HEV RNA has not yet been detected in domestic cats. The high percentage of donors with HEV antibodies in our area contrasts with the low recorded incidence of autochthonous hepatitis E in France and other industrialized countries (,). Even though we documented dozens of hepatitis E cases in Midi-Pyrénées during the past decade, the remarkably high seroprevalence in this area suggests that most infections must be subclinical or unrecognized. However, in susceptible persons, such as organ transplant recipients and patients with chronic liver disease, the consequences of HEV infection are grave and raise public health, as well as food and environmental safety, concerns. HEV is highly endemic to the Midi-Pyrénées region in southwestern France. We showed that seroprevalence increases with age and is associated with rural residence, hunting, and exposure to cats. These associations became apparent only when we used a sensitive assay to detect HEV IgG. The reasons for the high HEV prevalence in this population are uncertain but may be due, at least partially, to the culinary culture of the local community. Thorough cooking of game meat and pork products would help minimize the risk for HEV infection and could form part of a public health initiative in this area.
  15 in total

1.  A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.

Authors:  Richard Bendall; Vic Ellis; Samreen Ijaz; Rachel Ali; Harry Dalton
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

2.  A national survey of acute hepatitis E in France.

Authors:  C Renou; X Moreau; A Pariente; J-F Cadranel; E Maringe; T Morin; X Causse; J-L Payen; J Izopet; E Nicand; M Bourlière; G Penaranda; J Hardwigsen; R Gerolami; J-M Péron; N Pavio
Journal:  Aliment Pharmacol Ther       Date:  2008-03-14       Impact factor: 8.171

Review 3.  From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety.

Authors:  Xiang-Jin Meng
Journal:  Virus Res       Date:  2011-02-21       Impact factor: 3.303

4.  Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer.

Authors:  Kazuaki Takahashi; Naoto Kitajima; Natsumi Abe; Shunji Mishiro
Journal:  Virology       Date:  2004-12-20       Impact factor: 3.616

5.  Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands.

Authors:  M Bouwknegt; B Engel; M M P T Herremans; M A Widdowson; H C Worm; M P G Koopmans; K Frankena; A M de Roda Husman; M C M De Jong; W H M Van Der Poel
Journal:  Epidemiol Infect       Date:  2007-06-20       Impact factor: 2.451

Review 6.  Hepatitis E: an emerging infection in developed countries.

Authors:  Harry R Dalton; Richard Bendall; Samreen Ijaz; Malcolm Banks
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

7.  High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France.

Authors:  Jean Michel Mansuy; Florence Legrand-Abravanel; Jean Pierre Calot; Jean Marie Peron; Laurent Alric; Sylvie Agudo; Henri Rech; François Destruel; Jacques Izopet
Journal:  J Med Virol       Date:  2008-02       Impact factor: 2.327

8.  Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease.

Authors:  Harry R Dalton; William Stableforth; Prem Thurairajah; Simon Hazeldine; Rene Remnarace; Warshow Usama; Liz Farrington; Noor Hamad; Cyril Sieberhagen; Vic Ellis; Jonathan Mitchell; S Hyder Hussaini; Malcolm Banks; Samreen Ijaz; Richard P Bendall
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-08       Impact factor: 2.566

9.  Prevalence of anti-hepatitis E virus antibodies in French blood donors.

Authors:  Annie Boutrouille; Labib Bakkali-Kassimi; Catherine Crucière; Nicole Pavio
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

10.  Hepatitis E virus genotype 3 diversity, France.

Authors:  Florence Legrand-Abravanel; Jean-Michel Mansuy; Martine Dubois; Nassim Kamar; Jean-Marie Peron; Lionel Rostaing; Jacques Izopet
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

View more
  123 in total

1.  Hepatitis: hepatitis E and decompensated chronic liver disease.

Authors:  Harry R Dalton
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-26       Impact factor: 46.802

2.  Hepatitis e: the 'new kid on the block' or an old friend?

Authors:  Harry R Dalton
Journal:  Transfus Med Hemother       Date:  2014-02       Impact factor: 3.747

3.  Hepatitis E virus infection in a patient with suspected drug-induced liver injury.

Authors:  Ashfaque Memon; Jose Miranda
Journal:  BMJ Case Rep       Date:  2017-01-31

4.  Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes.

Authors:  Yukihiko Kimura; Akihiko Gotoh; Seiichiro Katagiri; Yuji Hoshi; Shigeharu Uchida; Atsushi Yamasaki; Yoko Takahashi; Katsuyuki Fukutake; Toru Kiguchi; Kazuma Ohyashiki
Journal:  Blood Transfus       Date:  2013-10-02       Impact factor: 3.443

5.  Molecular Investigation on the Presence of Hepatitis E Virus (HEV) in Wild Game in North-Western Italy.

Authors:  Laura Serracca; Roberta Battistini; Irene Rossini; Walter Mignone; Simone Peletto; Claudia Boin; Giancarlo Pistone; Riccardo Ercolini; Carlo Ercolini
Journal:  Food Environ Virol       Date:  2015-05-26       Impact factor: 2.778

6.  Hepatitis e virus: current concepts and future perspectives.

Authors:  Harry R Dalton; Suzan D Pas; Richie G Madden; Annemiek A van der Eijk
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

7.  A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors.

Authors:  Enea Spada; Simonetta Pupella; Giulio Pisani; Roberto Bruni; Paola Chionne; Elisabetta Madonna; Umbertina Villano; Matteo Simeoni; Sara Fabi; Giuseppe Marano; Cinzia Marcantonio; Patrizio Pezzotti; Anna R Ciccaglione; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-05-04       Impact factor: 3.443

8.  Serological evidence for a hepatitis e virus-related agent in goats in the United States.

Authors:  B J Sanford; S U Emerson; R H Purcell; R E Engle; B A Dryman; T E Cecere; V Buechner-Maxwell; D P Sponenberg; X J Meng
Journal:  Transbound Emerg Dis       Date:  2012-08-22       Impact factor: 5.005

Review 9.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

10.  Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort Study.

Authors:  Heléne Norder; Marie Karlsson; Åsa Mellgren; Jan Konar; Elisabeth Sandberg; Anders Lasson; Maria Castedal; Lars Magnius; Martin Lagging
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.